3-hydroxyphenyltrimethylammonium has been researched along with edrophonium in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cronnelly, R; Fisher, DM; Hennis, PJ; Miller, RD; Sharma, M | 1 |
1 other study(ies) available for 3-hydroxyphenyltrimethylammonium and edrophonium
| Article | Year |
|---|---|
Metabolites of neostigmine and pyridostigmine do not contribute to antagonism of neuromuscular blockade in the dog.
Topics: Animals; Dogs; Dose-Response Relationship, Drug; Edrophonium; Kinetics; Neostigmine; Neuromuscular Blocking Agents; Pyridinium Compounds; Pyridostigmine Bromide; Quaternary Ammonium Compounds | 1984 |